Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1725 of 1863 entries
View as:

Quality of Life Among Survivors of Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00598728 Org: User:
Start: 05/31/05 End: 04/30/16 Due: 04/30/17

Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00024258 Org: User:
Start: 03/31/01 End: 05/31/09 Due: 05/31/10

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04462471 Org: User:
Start: 06/26/20 End: 09/29/23 Due: 09/29/24

Axitinib and Nivolumab for the Treatment of Mucosal Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT05384496 Org: User:
Start: 05/17/22 End: 05/31/26 Due: 05/31/27

A Registry for Patients With Multifocal Ground Glass Opacities (GGOs)

Phase: N/A Priority: Normal
NCT ID: NCT03802981 Org: User:
Start: 01/09/19 End: 01/31/26 Due: 01/31/27

The Impact of Androgen Ablation Therapy on Cognitive Functioning and Functional Status in Men With Prostate Cancer Age 65 and Older

Phase: N/A Priority: Normal
NCT ID: NCT00579072 Org: User:
Start: 08/31/06 End: 12/31/25 Due: 12/31/26

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04761055 Org: User:
Start: 01/29/21 End: 01/31/26 Due: 01/31/27

18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT02348749 Org: User:
Start: 01/31/15 End: 03/17/25 Due: 03/17/26

Spanish Translation of the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)

Phase: N/A Priority: Normal
NCT ID: NCT01436240 Org: User:
Start: 09/30/11 End: 05/31/17 Due: 05/31/18

Temozolomide for Relapsed Sensitive or Refractory Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00740636 Org: User:
Start: 08/31/08 End: 02/28/13 Due: 02/28/14

A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide

Phase: N/A Priority: Normal
NCT ID: NCT04497961 Org: User:
Start: 08/28/20 End: 08/31/25 Due: 08/31/26

A Study of Tafasitamab and Lenalidomide in People With Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05788289 Org: User:
Start: 03/14/23 End: 08/01/24 Due: 08/01/25

A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)

Phase: N/A Priority: Normal
NCT ID: NCT00592111 Org: User:
Start: 03/31/96 End: 01/31/08 Due: 01/31/09

Quality of Life Among Long-Term Survivors of Resected Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00598546 Org: User:
Start: 09/30/04 End: 06/30/09 Due: 06/30/10

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Phase: N/A Priority: Normal
NCT ID: NCT03430895 Org: User:
Start: 01/31/18 End: 02/10/21 Due: 02/10/22

A Study of Surgical Techniques During Cystectomy

Phase: N/A Priority: Normal
NCT ID: NCT06703476 Org: User:
Start: 11/21/24 End: 11/30/28 Due: 11/30/29

Tislelizumab in People With Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06529523 Org: User:
Start: 07/26/24 End: 07/31/28 Due: 07/31/29

Irinotecan and Carboplatin as Upfront Window Therapy in Treating Patients With Newly Diagnosed Intermediate-Risk or High-Risk Rhabdomyosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00077285 Org: User:
Start: 10/31/03 End: 10/31/25 Due: 10/31/26

Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01967095 Org: User:
Start: 10/15/13 End: 11/08/18 Due: 11/08/19

Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual Function

Phase: N/A Priority: Normal
NCT ID: NCT00588081 Org: User:
Start: 05/31/01 End: 08/31/16 Due: 08/31/17

Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00598741 Org: User:
Start: 07/31/04 End: 04/30/14 Due: 04/30/15

Trial of Donor T Cells Sensitized With Pentadecapeptides of the CMV-PP65 Protein for the Treatment of Cytomegalovirus (CMV) Infections Following Allogeneic Hematopoietic Stem Cell Transplants

Phase: N/A Priority: Normal
NCT ID: NCT00674648 Org: User:
Start: 08/31/07 End: 03/31/14 Due: 03/31/15

An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

Phase: N/A Priority: Normal
NCT ID: NCT05420064 Org: User:
Start: 12/01/22 End: 11/30/26 Due: 11/30/27

Addition of Ipilimumab (MDX-010) To Isolated Limb Infusion (ILI) With Standard Melphalan and Dactinomycin In The Treatment of Advanced Unresectable Melanoma of The Extremity

Phase: N/A Priority: Normal
NCT ID: NCT01323517 Org: User:
Start: 02/28/11 End: 08/14/17 Due: 08/14/18

Changes in Reproductive and Sexual Health in People With Early Onset Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04812912 Org: User:
Start: 03/18/21 End: 03/18/26 Due: 03/18/27